scholarly journals Exercise as a Therapeutic Intervention in Gestational Diabetes Mellitus

Endocrines ◽  
2021 ◽  
Vol 2 (2) ◽  
pp. 65-78
Author(s):  
Konstantina Dipla ◽  
Andreas Zafeiridis ◽  
Gesthimani Mintziori ◽  
Afroditi K. Boutou ◽  
Dimitrios G. Goulis ◽  
...  

Gestational Diabetes Mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. Regular exercise is important for a healthy pregnancy and can lower the risk of developing GDM. For women with GDM, exercise is safe and can affect the pregnancy outcomes beneficially. A single exercise bout increases skeletal muscle glucose uptake, minimizing hyperglycemia. Regular exercise training promotes mitochondrial biogenesis, improves oxidative capacity, enhances insulin sensitivity and vascular function, and reduces systemic inflammation. Exercise may also aid in lowering the insulin dose in insulin-treated pregnant women. Despite these benefits, women with GDM are usually inactive or have poor participation in exercise training. Attractive individualized exercise programs that will increase adherence and result in optimal maternal and offspring benefits are needed. However, as women with GDM have a unique physiology, more attention is required during exercise prescription. This review (i) summarizes the cardiovascular and metabolic adaptations due to pregnancy and outlines the mechanisms through which exercise can improve glycemic control and overall health in insulin resistance states, (ii) presents the pathophysiological alterations induced by GDM that affect exercise responses, and (iii) highlights cardinal points of an exercise program for women with GDM.

Nutrients ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 506 ◽  
Author(s):  
Susana Contreras-Duarte ◽  
Lorena Carvajal ◽  
María Jesús Garchitorena ◽  
Mario Subiabre ◽  
Bárbara Fuenzalida ◽  
...  

Gestational diabetes mellitus (GDM) associates with fetal endothelial dysfunction (ED), which occurs independently of adequate glycemic control. Scarce information exists about the impact of different GDM therapeutic schemes on maternal dyslipidemia and obesity and their contribution to the development of fetal-ED. The aim of this study was to evaluate the effect of GDM-treatments on lipid levels in nonobese (N) and obese (O) pregnant women and the effect of maternal cholesterol levels in GDM-associated ED in the umbilical vein (UV). O-GDM women treated with diet showed decreased total cholesterol (TC) and low-density lipoproteins (LDL) levels with respect to N-GDM ones. Moreover, O-GDM women treated with diet in addition to insulin showed higher TC and LDL levels than N-GDM women. The maximum relaxation to calcitonin gene-related peptide of the UV rings was lower in the N-GDM group compared to the N one, and increased maternal levels of TC were associated with even lower dilation in the N-GDM group. We conclude that GDM-treatments modulate the TC and LDL levels depending on maternal weight. Additionally, increased TC levels worsen the GDM-associated ED of UV rings. This study suggests that it could be relevant to consider a specific GDM-treatment according to weight in order to prevent fetal-ED, as well as to consider the possible effects of maternal lipids during pregnancy.


2018 ◽  
Vol 17 (1) ◽  
pp. 52-71 ◽  
Author(s):  
Susana Contreras-Duarte ◽  
Lorena Carvajal ◽  
Bárbara Fuenzalida ◽  
Claudette Cantin ◽  
Luis Sobrevia ◽  
...  

Dyslipidaemia occurs in pregnancy to secure foetal development. The mother shows a physiological increase in plasma total cholesterol and Triglycerides (TG) as pregnancy progresses (i.e. maternal physiological dyslipidaemia in pregnancy). However, in some women pregnancy-associated dyslipidaemia exceeds this physiological adaptation. The consequences of this condition on the developing fetus include endothelial dysfunction of the foetoplacental vasculature and development of foetal aortic atherosclerosis. Gestational Diabetes Mellitus (GDM) associates with abnormal function of the foetoplacental vasculature due to foetal hyperglycaemia and hyperinsulinaemia, and associates with development of cardiovascular disease in adulthood. Supraphysiological dyslipidaemia is also detected in GDM pregnancies. Although there are several studies showing the alteration in the maternal and neonatal lipid profile in GDM pregnancies, there are no studies addressing the effect of dyslipidaemia in the maternal and foetal vasculature. The literature reviewed suggests that dyslipidaemia in GDM pregnancy should be an additional factor contributing to worsen GDM-associated endothelial dysfunction by altering signalling pathways involving nitric oxide bioavailability and neonatal lipoproteins.


2002 ◽  
Vol 39 (4) ◽  
pp. 311-319 ◽  
Author(s):  
Michael M. Hannemann ◽  
William G. Liddell ◽  
Angela C. Shore ◽  
Penny M. Clark ◽  
John E. Tooke

2016 ◽  
Vol 128 (4) ◽  
pp. 819-827 ◽  
Author(s):  
Kym J. Guelfi ◽  
Ming Jing Ong ◽  
Nicole A. Crisp ◽  
Paul A. Fournier ◽  
Karen E. Wallman ◽  
...  

2013 ◽  
Vol 37 ◽  
pp. S49
Author(s):  
Faith Delos-Reyes ◽  
Jennifer Price ◽  
Mireille Landry ◽  
Ananya Banerjee ◽  
Lorraine Lipscombe

2019 ◽  
Vol 74 (5) ◽  
pp. 303-312 ◽  
Author(s):  
Beata Makaruk ◽  
Anna Galczak-Kondraciuk ◽  
Wanda Forczek ◽  
Weronika Grantham ◽  
Małgorzata Charmas

2015 ◽  
Vol 100 (3) ◽  
pp. 231-238 ◽  
Author(s):  
Luis Sobrevia ◽  
Rocío Salsoso ◽  
Tamara Sáez ◽  
Carlos Sanhueza ◽  
Fabián Pardo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document